A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses
Clinical trial NCT05310032 · COMPLETED
Trial details
- NCT number
- NCT05310032
- Sponsor
- Glaceum
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2022-12-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.